Relmada Therapeutics, Inc. Common Stock (RLMD)

Typically moves ±5.23% on earnings
EARNINGS ANALYTICS
search

Relmada Therapeutics, Inc. Common Stock (RLMD) has a 14-report earnings history dating back to Mar 23, 2022. Its average absolute post-earnings move is ±5.23%, and 42.9% of those reactions were positive. Its largest post-earnings gain was +8.55% (Nov 10, 2022) and its largest decline was -18.11% (Mar 19, 2024).

Earnings reactions

How RLMD moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

14

Avg Abs. Movement

±5.23%

Positive %

42.9%

Negative %

57.1%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 06, 2026 ☽ POST -8.19% open_in_new
May 12, 2026 ☽ POST +0.67% open_in_new
Mar 20, 2026 ☽ POST -3.47% open_in_new
Nov 13, 2025 ☽ POST +1.8% open_in_new
event

Earnings Count

14

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.23%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 20 →
20
Funds holding
$182377942
Total value held
Buying
16 added · 3 reduced
Janus Henderson Group Plc
$76892206 NEW BUY
Blackrock, Inc.
$51393319 +475.92%
State Street Corp
$17421446 +605.12%
Ameriprise Financial Inc
$13410767 NEW BUY
Bank Of America Corp /De/
$5619449 +544.79%

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
8-K 20260908 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
10-Q 20260806 open_in_new SEC.gov
8-K 20260806 open_in_new SEC.gov
SCHEDULE 13G 20260729 open_in_new SEC.gov
8-K 20260728 open_in_new SEC.gov
SCHEDULE 13G 20260622 open_in_new SEC.gov
S-8 20260618 open_in_new SEC.gov
SCHEDULE 13G 20260609 open_in_new SEC.gov
8-K 20260528 open_in_new SEC.gov

Frequently asked about RLMD earnings

How much does RLMD stock move after earnings? expand_more

Over 14 reports, RLMD has moved an average of ±5.23% the session after earnings, closing higher 42.9% of the time.

What was RLMD's biggest post-earnings move? expand_more

RLMD's largest post-earnings gain on record was +8.55% on Nov 10, 2022, and its largest decline was -18.11% on Mar 19, 2024.

Where can I find Relmada Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Relmada Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers